_256_384.jpg)
News | March 01, 2024
Suven announces merger of Cohance Lifesciences
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
BHL will undertake the development and supply of these molecules
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Subscribe To Our Newsletter & Stay Updated
